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DockingAbstract Caspase-3 has become an attractive target in the treatment of many diseases such as
Alzheimer, Parkinson’s, myocardial infarction and cancer. In the present study, molecular three-
dimensional quantitative structure activity relationship (3D-QSAR) and docking studies were
performed on a series of caspase-3 activators. Comparative molecular ﬁeld analysis (CoMFA),
comparative molecular similarity indices analysis (CoMSIA) and step-wise k-nearest neighboring
molecular ﬁeld analysis [(SW) kNN MFA] were performed to gain insight into the key structural
factors affecting the activity. The results of 3D-QSAR are reliable and signiﬁcant having high
predictive (q2) ability showing good correlation between predicted and observed activity. The lower
value of standard error of estimation shows that most of the observed values cluster fairly close to
the regression line. Molecular docking was performed with the GOLD docking program used to
explore the binding mode between the ligands and the receptor.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Cancer is a major dilemma worldwide and is the principal
cause of mortality in developed countries. Nearly one in two
men and more than one in three women in the United States
will be diagnosed with cancer at some point in his or her life-
time (Carson and Lois, 1995; Thun et al., 2006). One of the
most difﬁcult problems arising during cancer therapy is the
occurrence of cancer cell invasion responsible for the spreadtivators.
2 A. Vaidya et al.of tumor cells throughout the body (Suk et al., 2009; Sohn
et al., 2010). At present, a wide range of cytotoxic drugs with
different mechanisms of action are used to treat human cancer,
either alone or in combination. Diverse groups of molecules
are involved in the apoptosis induced cytotoxicity (Zhang
et al., 2003; Silva et al., 2007). Induction of apoptosis by novel
caspase substrates has become an area of intense research in
oncology (Thornberry, 1998). Caspases, a group of cysteine
proteases (hence the C in caspase) cleave their substrates after
aspartic acid residues (hence aspase) and are the key execution-
ers of apoptosis (Mohr and Zwacka, 2007; Syed et al., 2005).
Caspases are classiﬁed into two classes i.e. initiator caspases
(caspase 2, caspase 8, caspase 9 and caspase 10) and effector
caspases (caspase 3, caspase 6 and caspase 7), based on the
presence of a large prodomain at their amino-terminal region
(Salvesen and Dixit, 1997; Marques et al., 2003; Leonard
and Roy, 2006).
Caspase-3 a frequently activated death protease is the pri-
mary target for a number of anticancer agents. N-phenylnico-
tinamide, was ﬁrst discovered as a series of novel potent
apoptosis inducers that interact with tubulin (Cai et al.,
2001; Dutchowicz et al., 2006). Zhang et al. (2003) reported
the discovery and biological characterization of 3-aryl-5-aryl-
1,2,4-oxadiazoles as a novel apoptosis inducer with tumor
selective properties owing to caspase-3 activation.
Several molecular modeling aspects have been employed in
the development of potent and selective caspase-3 activators.
In this work, three-dimensional quantitative structure activity
relationship (3D-QSAR) and molecular docking approaches
were performed to study these caspase-3 activators. 3D-QSAR
methods, i.e., comparative molecular ﬁeld analyses (CoMFA),
comparative molecular similarity indices analyses (CoMSIA)
and step-wise k-nearest neighboring molecular ﬁeld analysis
[(SW) kNNMFA] are most valuable techniques, which involve
the generation of a common three dimensional lattice around a
set of molecules and calculation of interaction energies at the
lattice points (Ravichandran and Agrawal, 2007;
Ravichandran et al., 2007, 2008; Prashanthakumar and
Nanjan 2009; V-Life). Docking studies were also performed
to explore receptor-based conformation or binding pocket
for each compound and consequently derived more reliable
models.
2. Material and methods
2.1. Data set
A data set of thirty-two 3-aryl-5-aryl-1,2,4-oxadiazole deriva-
tives with caspase-3 enzyme activity that induced cytotoxicity
on the T47D cell line was used in the present study (Table 1)
(Zhang et al., 2005a,b; Kemnitzer et al., 2009). Test and train-
ing set contained a diverse set of compounds with low, moder-
ate and high biological activity.
2.2. Molecular structure and alignment
The 3D QSAR molecular modeling and statistical analysis
were performed using the molecular modeling package SYB-
YL Version 6.7 (Tripos Inc., 2001) and V-Life Molecular
Design Suit (MDS) software Version 3.5 using the CoMFA,
CoMSIA and [(SW) kNN MFA] methods respectively. ThePlease cite this article in press as: Vaidya, A. et al., CoMFA, CoMSIA, kNN MFA a
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built on the workspace of molecular modeling softwares SYB-
YL and V-Life MDS. Energy minimization was carried out
using the standard tripos force ﬁeld with distance dependent-
dielectric function, energy gradient of 0.001 kcal/mol A˚ and
an iteration limit of 10,000. Partial charges for all the mole-
cules were assigned using the Gasteiger–Huckel method and
they were submitted for a conformational search protocol.
Bioactive conformations and molecular alignment are two
imperative parameters to build more consistent 3D QSAR
models. Structure alignment is considered as one of the most
sensitive steps in 3D QSAR done with a template based align-
ment. The most active compound 10e was used as a template
and each molecule was superimposed on the template via the
ﬁeld ﬁt alignment (Figs. 1 and 2) (Jain et al., 2010; Vaidya
et al., 2011).
2.3. Generation of CoMFA, CoMSIA and [(SW) kNN MFA]
ﬁelds
After alignment molecules were placed in a common rectangu-
lar grid that extended 4 A˚ units beyond the aligned molecules
in all directions with a grid step size of 2 A˚; a probe sp3 hybrid-
ized carbon atom with +1 charge and Van Der Waals radius
of 1.52 A˚ was employed.
In CoMFA, steric and electrostatic ﬁeld descriptors were
calculated with a default cut-off of 30 kcal/mol whereas for
CoMSIA all ﬁve force ﬁeld properties (i.e. steric, electrostatic,
hydrophobic, hydrogen-bond donor and hydrogen-bond
acceptor) were determined at a 30-kcal/mol energy cut-off,
which meant that energy ﬁelds greater than 30 kcal/mol are
curtailed to that value, and thus can avoid inﬁnite energy val-
ues inside the molecule.
Similar to CoMFA in the [(SW) kNN MFA] method steric
and electrostatic ﬁelds were generated with a default energy of
30 kcal/mol.
2.4. Partial Least-Square (PLS) regression analysis and
validation of 3D-QSAR model
Partial Least-Square (PLS) regression analysis was used to
construct a linear correlation between energy ﬁelds (indepen-
dent variables) with anticancer activity values (dependent var-
iable) and cross-validation was done using the leave-one-out
(LOO) method with a 2.0 kcal/mol column ﬁlter for CoMFA,
CoMSIA and [(SW) kNN MFA] analyses.
The ﬁnal models were validated on the basis of obtained
optimum number of components (N) yielding the highest
cross-validated r2 (q2) value with a minimum standard of error.
2.5. Molecular docking
Docking studies were employed to locate the appropriate bind-
ing orientations and conformations of these oxadiazole deriv-
atives interacting with caspase-3 using the docking program
GOLD. Gold is a fast, ﬂexible docking method that uses an
incremental construction algorithm to place ligands into an
active site. By default, the docking program produces 10
docked structures for each 1,2,4-oxadiazole derivative. The
conformation with the lowest docking energy in the most pop-
ulated cluster is selected as the possible ‘active’ conformationnd docking studies of 1,2,4-oxadiazole derivatives as potent caspase-3 activators.
Table 1 1,2,4-Oxadiazole analogs and their experimental caspase-3 activator activity
O N
N Ar2Ar1
S. No. Ar1 Ar2 Activity T47D (EC50 nM) pIC50 (T47D)
1d S
Cl
CF3
0.0012 2.9172
4a
S
Cl
Cl 0.0018 2.7520
4b S
Cl
0.0028 2.5496
4c
S
Cl
O
CF3
0.0009 3.0506
4d
S
Cl
O
0.0042 2.3799
4e
S
Cl
CH3 0.0037 2.4365
4g
S
Cl CF3
0.0009 3.0456
4h S
Cl Cl
Cl
0.0014 2.8508
4i
S
Cl CF3
Cl
0.0009 3.0315
4j
S
Cl
Cl
CH3
0.0009 3.0406
(continued on next page)
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Table 1 (continued)
S. No. Ar1 Ar2 Activity T47D (EC50 nM) pIC50 (T47D)
4k S
Cl N
CF3
0.0014 2.8416
4l S
Cl N
Cl
0.0016 2.7986
4m S
Cl
N
CF3
0.0009 3.0362
4n S
Cl
N
Cl
0.0008 3.1249
4o S
Br
Cl
0.0033 2.4789
4v O
Cl
NO2
0.0020 2.7055
10a O
Br
Cl
0.0011 2.9666
10b O
Cl
Cl
0.0017 2.7595
10c O Cl
0.0174 1.7595
10d O
Br
CF3
0.0020 2.6968
10e O
Cl
CF3
0.0005 3.2840
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Table 1 (continued)
S. No. Ar1 Ar2 Activity T47D (EC50 nM) pIC50 (T47D)
10f O
Br N
Cl
0.0016 2.7932
10g O
Br N
CF3
0.0006 3.2147
10h O
Cl N
Cl
0.0011 2.9547
11a S
Cl CH3
Cl
0.0017 2.7696
11b S
Cl NH2
Cl
0.0024 2.6198
11c S
Cl
NH2
Cl
0.0031 2.5086
11d S
Cl
Cl
Br
0.0045 2.3468
11e O
Br
Cl
CH3
0.0011 2.9580
11f O
Br
N
Cl
CH3
0.0009 3.0268
11g O
Br
Cl
Br
0.0022 2.6575
(continued on next page)
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Figure 1 Field ﬁt alignment of 1,2,4-oxadiazoles derivatives
using SYBYL 6.7.
Figure 2 Field ﬁt alignment of 1,2,4-oxadiazoles derivatives
using V-Life MDS 3.5.
Table 1 (continued)
S. No. Ar1 Ar2 Activity T47D (EC50 nM) pIC50 (T47D)
11h
O
Br
Cl
OH
0.0029 2.5376
Table 2 The comparison of 3D QSAR models of CoMFA,
CoMSIA and [(SW) kNN MFA].
Statistics CoMFA CoMSIA [(SW) kNN MFA]
PCs 4 6 3
r2 0.817 0.822 0.8413
q2 0.632 0.577 0.6278
pred_r2 – – 0.5078
SEE 0.152 0.150 0.1852
F value 44.177 38.623 25.434
P value 0.0 0.0 –
Field contribution
Steric 0.524 0. 211 S_458 (0.34)
Electrostatic 0.476 0.289 E_472 (0.48)
E_284 (0.18)
Hydrophobicity – 0.332 –
H bond acceptor – 0.123 –
H bond donor – 0.045 –
igure 3 CoMFA contour plots for steric and electrostatic
egions. Green counters indicate the bulky group region, whereas
e yellow counter indicates the region where bulky groups are not
equired. Blue counters indicate the region needed for electroneg-
tive contribution, whereas red counters indicate the region where
lectropositive contribution is required.
6 A. Vaidya et al.against the 1RE1 active site. In the present study, 32 com-
pounds were successfully docked into the 1RE1 site.
The X-ray crystal structure of caspase-3 taken from the
Protein Data Bank (pdb: 1RE1) was used to dock. At the
beginning of docking, all the water molecules were removed,
hydrogen atoms added and AMBER7FF99 charges to the pro-
tein were applied.
It is critical to search for the binding pocket of the prepared
protein in docking studies. In Surﬂex-docking, the binding
pockets can be deﬁned either from a cocrystallized ligand or
from a list of residues known to be part of the interacting site
(or predicted de novo). The active site was deﬁned within 5 A˚
surrounding to the co-crystallized ligand and the speciﬁc resi-
dues and constraints information were obtained from crystal-
lographic data as well as an earlier study. The docking poses
were ranked by Gold docking and the top ten poses were
selected. The ligands were then docked inside a cubic GRID
box centered at the midpoint between the Cys205 andPlease cite this article in press as: Vaidya, A. et al., CoMFA, CoMSIA, kNN MFA a
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in the dataset. In most cases the chosen pose was the top-
ranked solution.
3. Result and discussion
To derive 3D QSAR models, best selected model compound
No. 4c, 4e, 4l, 4n, 10g and 11g were set as test set compounds,
while the remaining were training set compounds.F
r
th
r
a
end docking studies of 1,2,4-oxadiazole derivatives as potent caspase-3 activators.
igure 4 Correlation between the experimental and predicted
ctivities of the developed CoMFA model. (¤ Represent training
data set, d Represent test data set).
Table 3 The comparison of PLS statistics results of 3D QSAR Models of CoMFA, CoMSIA and [(SW) kNN MFA] with Gold doc
score.
Comp. No. Actual pIC50 3D QSAR Docking
CoMFA
Predicted
pIC50
CoMFA
Residual
CoMSIA
Predicted
pIC50
CoMSIA
Residual
[(SW) kNN MFA]
Predicted
pIC50
[(SW) kNN MFA]
Residual
Gold Score
1d 2.9172 2.7606 0.1566 2.8591 0.0581 2.9797 0.0625 50.7710
4a 2.7520 2.5558 0.1962 2.7075 0.0445 2.797 0.045 48.3245
4b 2.5496 2.4697 0.0799 2.6115 0.0619 2.809 0.2594 47.1051
4c 3.0506 2.7496 0.301 2.8744 0.1762 3.1098 0.0592 51.6726
4d 2.3799 2.3634 0.0165 2.3601 0.0198 2.1979 0.182 52.8594
4e 2.4365 2.6706 0.2341 2.5715 0.135 2.4972 0.0607 50.8465
4g 3.0456 3.0214 0.0242 2.9884 0.0572 3.0809 0.0353 50.3570
4h 2.8508 2.8565 0.0057 2.9465 0.0957 2.6909 0.1599 50.2127
4i 3.0315 3.0237 0.0078 3.0253 0.0062 3.2002 0.1687 50.3041
4j 3.0406 3.0195 0.0211 2.9422 0.0984 3.0763 0.0357 56.3197
4k 2.8416 2.8221 0.0195 2.9434 0.1018 2.8902 0.0486 50.2944
4l 2.7986 2.6402 0.1584 2.8036 0.005 2.6999 0.0987 51.4326
4m 3.0362 3.0395 0.0033 3.0703 0.0341 3.197 0.1608 49.3034
4n 3.1249 2.9534 0.1715 2.9355 0.1894 3.1213 0.0036 50.9304
4o 2.4789 2.6177 0.1388 2.7238 0.2449 2.2991 0.1798 50.9680
4v 2.7055 2.7565 0.051 2.7137 0.0082 2.5701 0.1354 50.2641
10a 2.9666 2.8706 0.096 2.7724 0.1942 2.8731 0.0935 49.3839
10b 2.7595 2.7674 0.0079 2.7528 0.0067 2.6891 0.0704 49.6805
10c 1.7595 1.7815 0.022 1.8098 0.0503 1.7897 0.0302 47.3030
10d 2.6968 2.8924 0.1956 2.9267 0.2299 2.4789 0.2179 50.2051
10e 3.2840 2.9656 0.3184 2.9098 0.3742 3.4076 0.1236 51.2655
10f 2.7932 2.9397 0.1465 2.8538 0.0606 2.6762 0.117 49.3028
10g 3.2147 3.1878 0.0269 3.0555 0.1592 3.1237 0.091 49.2035
10h 2.9547 2.8354 0.1193 2.8344 0.1203 3.17979 0.22509 49.8395
11a 2.7696 2.8163 0.0467 2.9568 0.1872 2.7349 0.0347 50.2123
11b 2.6198 2.7063 0.0865 2.6654 0.0456 2.8732 0.2534 49.4238
11c 2.5086 2.5936 0.085 2.4908 0.0178 2.5021 0.0065 45.9621
11d 2.3468 2.4373 0.0905 2.3735 0.0267 2.4012 0.0544 47.8606
11e 2.9580 2.8504 0.1076 2.8142 0.1438 3.2233 0.2653 49.3778
11f 3.0268 3.0047 0.0221 3.1097 0.0829 3.0331 0.0063 50.8911
11g 2.6575 2.6257 0.0318 2.4664 0.1911 2.7183 0.0608 48.1746
11h 2.5376 2.6775 0.1399 2.4605 0.0771 2.5809 0.0433 47.6375
Studies of 1,2,4-oxadiazole derivatives as potent caspase-3 activators 7The ﬁnal model was developed with an optimum number of
components (N) yielding the highest crossvalidated correlation
coefﬁcient (q2) to avoid overﬁtted 3D QSARs. The other statis-
tical parameters included: number of components, the correla-
tion coefﬁcient (r), coefﬁcient of determination (r2), r2 for
external test set (pred_r2), covariance ration (F) and standard
error (r2 se).
3.1. CoMFA results
3D-QSAR models were built by template based alignment
method in SYBYL Molecular design Software (Fig. 1).
For the selected CoMFA model, the cross-validated r2 (q2)
value was 0.632 with four principal components. The non-
cross-validated r2 value was 0.817 with a standard error of esti-
mate 0.152 and a covariance ratio (F) of 44.177 (signiﬁcant at
99% level) (Table 2).
In CoMFA model, the steric parameter contributes 52.4%,
while the electrostatic parameter accounts for 47.6%. Contri-
butions of steric and electrostatic ﬁelds are shown in Fig. 3.
The correlation between experimental and predicted activity
for both training and test sets of compounds is shown inPlease cite this article in press as: Vaidya, A. et al., CoMFA, CoMSIA, kNN MFA an
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These results authenticate the good prediction ability of the
generated 3D QSAR model. The model summary dialog
box, showed the relative positions of the local ﬁelds around
aligned molecules that were important for activity variation
in the model (Fig. 3). Greater values of ‘‘Bio-Activity Measure-
ment’’ are correlated with more bulky near green, less bulkyF
ad docking studies of 1,2,4-oxadiazole derivatives as potent caspase-3 activators.
igure 6 CoMSIA contour plots for Steric and Electrostatic
egions. Green counters indicate the bulky group region, whereas
ellow counters indicate the region where less bulky groups are
equired. Blue counters indicate the region needed electronegative
ontribution.
Figure 7 CoMSIA contour plots for hydrophobic, hydrogen
bond donor and hydrogen bond acceptor ﬁelds region. The white
contour near suggest that hydrophobic groups will increase
activity and cyan contour decrease the activity. The purple and
orange contour for both hydrogen-bond donor favor and not
favor respectively in biological activity are absent. Similarly
contour for both hydrogen bond acceptor favor and disfavor are
showed by magenta contour and green contour respectively.
8 A. Vaidya et al.near yellow, more electro-negative near blue and less electro-
negative or electro-positive charge near red. A large green
counter near the 5th -position of the substituted furan ring
(Ar1 substitution) of 1,2,4-oxadiazole ring, indicates that the
bulky substitution favors the activity. Thus the presence of a
bulky substitution like bromine at 3rd position substitution
(compound 10a) encourages the activity. Naturally, presence
of chlorine atom at 3rd position in compound 10b is more
bulky than unsubstituted in compound 10c thus compound
10b is more active than compound 10c. Activity may further
be enhanced by replacing the chlorine atom with bromine
(i.e., compound 10b and 10a, respectively) due to more bulki-
ness of bromine as compared to chlorine. Less bulky group
substitution demonstrated with a yellow contour has no signif-
icant contribution to activity. Similarly, a blue contour near
the 3rd position of the substituted oxadiazole ring (Ar2), indi-
cates that substitution with electronegative groups like CN, F,
Cl increases the activity. Thus the presence of a triﬂuoromethyl
group in compounds (1d, 4i, 4k and 10g) rendered them more
active then compounds containing chlorine atoms (4a, 4h, 4l
and 10f), respectively. Electropositive substitution demon-
strated with a red contour has no contribution to activity.
3.2. CoMSIA results
For the selected CoMSIA model, the cross-validated r2 (q2)
value of the training set was 0.577 with the optimum number
of components (N) six. The regression coefﬁcient (r2) value
was 0.822 with standard error of estimation (SEE) 0.150 and
covariance ratio (F) of 38.623 (signiﬁcant at 99% level)
(Table 2). The correlation between experimental activity
(EA) and predicted activity (PA) is shown in Fig. 5 and
reported in Table 3. The CoMSIA model was externally
validated with the test set of compounds. These results demon-
strated that the obtained CoMSIA model has good self-
consistency (r2 > 0.8) and good prediction ability (q2 > 0.5).
The data clearly illustrate the steric, electrostatic, hydrogen-
bond donor, hydrogen-bond acceptor and hydrophobic ﬁeld
interaction in the CoMSIA model. In the CoMSIA model,
the contributions of the steric, electrostatic, hydrophobic,
hydrogen-bond acceptor and hydrogen bond donor ﬁelds were
21.1%, 28.9%, 33.2%, 12.3%, and 4.5%, respectively (Table 2)
and are represented graphically in Figs. 6 and 7. Similar to
CoMFA the presence of a green contour near the ﬁfth position
substituted oxadiazole derivatives (Ar1) indicated that theFigure 5 Correlation between the experimental and predicted
activities of the developed CoMSIA model. (¤ Represent training
data set, d Represent test data set).
Please cite this article in press as: Vaidya, A. et al., CoMFA, CoMSIA, kNN MFA a
Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.05.034F
r
y
r
cbulky groups at this position increased activity. The yellow
contour above the third position of the substituted phenyl sys-
tem (Ar2) indicates that bulky substituents at this position
decrease anticancer activity and small group substitution or
unsubstitution adds to the biological activity. The blue contour
near the third position of the substituted phenyl ring (Ar2)
indicates that the biological activity will increase by an electro-
negative group at the aforementioned positions (i.e., presence
of CF3 in compounds 1d, 4i, 4k and 10g) (Fig. 6). In the hydro-
phobic contour plots (Fig. 7) the white contour near 3rd and
5th positions of the substituted (Ar2 and Ar1, respectively)
oxadiazole ring system suggests that hydrophobic groups like
long chain alkyls at this position will add to activity, while a
diminutive cyan color indicates no signiﬁcant contribution of
hydrophobic disfavor in biological activity. The purple counter
near the 5th position of the substituted (Ar2) system suggests
that the hydrogen-bond donor favored activity and orange
contours for hydrogen-bond donor not favored are absent
showing no contribution in biological activity. Similarly con-
tours for both hydrogen bond acceptors that were favored
and disfavored (magenta contour and green contour respec-
tively) showed no signiﬁcant contribution in anticancer
activity.nd docking studies of 1,2,4-oxadiazole derivatives as potent caspase-3 activators.
igure 9 Correlation between the experimental and predicted
ctivities of the developed 3D QSAR by [(SW) kNNMFA] model.
¤ Represent training data set, d Represent test data set).
Studies of 1,2,4-oxadiazole derivatives as potent caspase-3 activators 93.3. [(SW) kNN MFA] results
In the [(SW) kNNMFA] method the results of uni-column sta-
tistics are summarized in Table 4, which show that the test is
interpolative. The ﬁnal model was selected on the basis of sta-
tistical parameters of the models. Finally, the model with good
internal and external predictive abilities was selected and is
shown in Table 2.
For the selected [(SW) kNN MFA] model, the cross-vali-
dated r2 (q2) value of the training set was 0.6278 with three
principal components. The non-cross-validated r2 value was
0.8413 with a standard error of estimate of 0.1852 and a
covariance ratio (F) of 25.434 (signiﬁcant at 99% level). The
predictive ability of the model was also conﬁrmed by external
pred_r2 having the value 0.5078 (Table 2).
In kNNMFAmodel, the steric parameter contributes 34%,
while the electrostatic parameter accounts for 66%. Contribu-
tions of steric and electrostatic ﬁelds are shown in the contri-
bution chart (Fig. 8). The correlations between experimental
and predicted activity for both training and test set of com-
pounds are shown in Table 3 and represented graphically in
Fig. 9 respectively, authenticate the good prediction ability
of the generated 3D QSAR model. The model summary dialog
box, showed the relative positions of both steric (green coun-
ter) and electrostatic regions (blue counter) around aligned
molecules that were important for activity variation in the
model (Fig. 10). Like CoMFA and CoMSIA, the green
counter near the 5th position of the substituted furan ring ofFigure 8 Contribution of steric and electrostatic ﬁelds g
Table 4 Unicolumn statistics of the training and test set.
Average Max. Min.
Training set 2.7943 3.2840 1.7595
Test size 2.7324 3.1249 2.4365
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(enerated in 3D QSAR by [(SW) kNN MFA] model.
Figure 10 kNN MFA contour plots for steric and electrostatic
regions. Green counters (S) indicate the steric region, whereas blue
counters (E) indicate region where electrostatic contribution are
required.
d docking studies of 1,2,4-oxadiazole derivatives as potent caspase-3 activators.
igure 12 Overlay of docked least potent oxadiazole compound
0c) at the active site of 1RE1 produced using the Gold program.
Figure 13 Correlation between the experimental activity and
dock score in Gold docking. (¤ Represent training data set, d
Represent test data set).
10 A. Vaidya et al.1,2,4-oxadiazole derivatives indicates that biological activity
can be improved by introducing a bulky group. Presence of
a blue counter near the 3rd and 5th positions of the substituted
furan and phenyl rings respectively of 1,2,4-oxadiazole deriva-
tives favors the presence of an electronegative group at afore-
mentioned positions.
Thus on the basis of 3D QSAR including CoMFA, CoM-
SIA and [(SW) kNN MFA] analyses the presence of bulky
groups such as ethoxy and phenoxy at the 5th position of the-
substituted furan ring of 1,2,4-oxadiazole derivatives and sub-
stitution of electronegative groups including di-ﬂuoro and
trimethy ﬂuoro at 3-substituted phenyl ring of 1,2,4-oxadiazole
derivatives are conducive to caspase-3 activating activity.
3.4. Docking results
It is well-reported that the anticancer mechanism of 3-Aryl-5-
aryl-1,2,4-oxadiazoles is due to caspase-3 activation.
Therefore, a docking study could offer understanding the pro-
tein–activator interactions and the structural features of the
active site of the protein.
All 1,2,4-oxadiazoles derivatives were docked into the bind-
ing site of caspase-3 and the energy scores of the activators are
also shown in Table 3, where precise correlations could be
found between docking scores and pIC50 values.
A complete overview of Gold docking is presented in
Figs. 11 and 12. Correlation between the docking score and
experimental activity is shown graphically in Fig. 13. It vividly
represents the interaction model of the most potent activator
10e with caspase-3. Docking studies showed that activator
10e is suitably situated at the binding site and there are various
interactions between it and the binding region of the enzyme.
The oxadiazole ring binds to the Caspase hinge region through
three key hydrogen bond interactions: (1) between the NH of
Cys205 and the O of the oxadiazole ring (2) between the NH
of Gly238 and the O of the oxadiazole ring (3) between the
NH of Cys205 and the N of the oxadiazole ring. Similarly
the 5th position of the substituted furan ring also forms hydro-
gen bonding between the NH of Gly238 and the O of the furan
ring. The hydrogen bonding distances observed were 2.319 A˚
(O_ _ _ H–NH– Cys205), 2.532 A˚ (O_ _ _ H–NH– Gly238),Figure 11 Overlay of docked highest potent oxadiazole com-
pound (10e) at the active site of 1RE1 produced using the Gold
program.
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(12.558 A˚ (N_ _ _ H–NH– Cys205) and 1.557 A˚ between the O
of the furan ring and NH of Gly238 (O_ _ _ H–NH– Gly238).
Fig. 12 shows the docking mode of the least active oxadiaz-
ole derivative compound 10c at the docking pocket. Similar to
compound 10e, compound 10c was also docked at the same
binding pockets having Cys205 and Gly238 amino acid resi-
dues. Results show that the O atom of the oxadiazole ring
forms a conservative hydrogen bond with Cys205 residue
(O_ _ _ H-NH-Cys205) having 2.414 A˚ bond distance. O atom
of the furan ring substituted at the 5th position of oxadiazole
(Ar1) also forms hydrogen bonding with NH of Gly238 (O_ _ _
H-NH-Gly238) with 1.594 A˚ bond length. The docking results
reported in Table 3, reveal that hydrogen bonding may be
responsible for activity, which may be further increased on
adding high electronegative substitutions.
Results of CoMFA, CoMSIA and [(SW) kNNMFA] meth-
ods, clearly show that the presence of an additional electroneg-
ative substitution at the 3rd position (Ar2 substitution) of
1,2,4-oxadiazole enhances biological activity. The presence of
electronegative substitution at the 3rd position is responsible
for biological activity and related data were further conﬁrmed
by docking results. Docking results clearly reveal that the pres-
ence of an additional electronegative group at 3rd position
substitution (10e) forms more hydrogen bonds with their sur-
rounding amino acid residues (3 hydrogen bonds with
Cys205 and Gly238) and thus possesses improved biological
activity in comparison to compounds that possess less numbernd docking studies of 1,2,4-oxadiazole derivatives as potent caspase-3 activators.
Studies of 1,2,4-oxadiazole derivatives as potent caspase-3 activators 11of electronegative substitutions (10c) at the aformentioned
positions. These data justify the results of 3D QSAR and dock-
ing results and also conﬁrm the utility of this hybrid technique.
4. Conclusions
In the present study, 3D-QSAR and molecular docking studies
were performed on a series of caspase-3 activators. The 3D-
QSAR studies were done using CoMFA, CoMSIA and
[(SW) kNN MFA] methods, which gained some insight into
the key structural factors affecting the bioactivity of these
inhibitors. The results of 3D-QSAR strongly suggest the pres-
ence of bulky group substitution near the 5th position of furan
ring (Ar1 substitution) whereas the presence of an electroneg-
ative group near the third position of substituted phenyl ring
(Ar2) is also conducive for the activity. Docking studies were
performed using Gold docking programs to obtain the bioac-
tive conformations for the whole dataset. In Gold docking the
activator with the highest potency (compound 10e) forms three
hydrogen bonds with residues of hinge region amino acids
Cys205 and Gly238. In spite of this, compounds having least
experimental activity (10c) show only two hydrogen bonds.
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